Novozymes A/S
CSE:NZYM B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NZYM B
Watchlist
Price: 403 DKK -3.93% Market Closed
Market Cap: 165.6B DKK
Have any thoughts about
Novozymes A/S?
Write Note

Novozymes A/S
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Novozymes A/S
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Novozymes A/S
CSE:NZYM B
EPS (Diluted)
kr10
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Chr Hansen Holding A/S
CSE:CHR
EPS (Diluted)
€1
CAGR 3-Years
-2%
CAGR 5-Years
0%
CAGR 10-Years
5%
P
Photocat A/S
STO:PCAT
EPS (Diluted)
kr0
CAGR 3-Years
20%
CAGR 5-Years
20%
CAGR 10-Years
N/A
No Stocks Found

Novozymes A/S
Glance View

Market Cap
165.6B DKK
Industry
Chemicals

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

NZYM B Intrinsic Value
124.53 DKK
Overvaluation 69%
Intrinsic Value
Price

See Also

What is Novozymes A/S's EPS (Diluted)?
EPS (Diluted)
10.9 DKK

Based on the financial report for Dec 31, 2023, Novozymes A/S's EPS (Diluted) amounts to 10.9 DKK.

What is Novozymes A/S's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
0%

Over the last year, the EPS (Diluted) growth was -18%. The average annual EPS (Diluted) growth rates for Novozymes A/S have been 3% over the past three years .

Back to Top